In the last trading session, 1.05 million Replimune Group Inc (NASDAQ:REPL) shares changed hands as the company’s beta touched 0.81. With the company’s per share price at $7.14 changed hands at -$0.35 or -4.67% during last session, the market valuation stood at $549.88M. REPL’s last price was a discount, traded about -138.1% off its 52-week high of $17.00. The share price had its 52-week low at $4.92, which suggests the last value was 31.09% up since then. When we look at Replimune Group Inc’s average trading volume, we note the 10-day average is 0.89 million shares, with the 3-month average coming to 752.73K.
Analysts gave the Replimune Group Inc (REPL) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.12. If we narrow down to specifics, the data shows that 0 out of 5 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended REPL as a Hold, 5 felt it is a Buy and 0 rated the stock as Underweight. Replimune Group Inc’s EPS for the current quarter is expected to be -0.69.
Replimune Group Inc (NASDAQ:REPL) trade information
Instantly REPL was in red as seen at the end of in last trading. With action -15.00%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -41.04%, with the 5-day performance at -15.00% in the red. However, in the 30-day time frame, Replimune Group Inc (NASDAQ:REPL) is -35.91% down. Looking at the short shares, we see there were 9.55 million shares sold at short interest cover period of 15.7 days.
The consensus price target for the stock as assigned by Wall Street analysts is 23, meaning bulls need an upside of 68.96% from its current market value. According to analyst projections, REPL’s forecast low is 19 with 27 as the target high. To hit the forecast high, the stock’s price needs a -278.15% plunge from its current level, while the stock would need to soar -166.11% for it to hit the projected low.
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -19.52%. The 2025 estimates are for Replimune Group Inc earnings to increase by 11.67%, but the outlook for the next 5-year period is at 13.91% per year.
REPL Dividends
Replimune Group Inc is expected to release its next quarterly earnings report on 2025-Feb-11.
Replimune Group Inc (NASDAQ:REPL)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 4.18% of Replimune Group Inc shares while 101.98% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 106.42%. There are 101.98% institutions holding the Replimune Group Inc stock share, with BAKER BROS. ADVISORS LP the top institutional holder. As of 2024-06-30, the company held 14.5193% of the shares, roughly 10.05 million REPL shares worth $90.41 million.
PRICE T ROWE ASSOCIATES INC /MD/ holds the second largest percentage of outstanding shares, with 13.8742% or 9.24 million shares worth $83.13 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were T. Rowe Price New Horizons Fund, Inc. and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund . With 4.73 shares estimated at $33.77 million under it, the former controlled 6.14% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held about 2.58% of the shares, roughly 1.99 shares worth around $14.2 million.
